Table 5jModel Parameters – Intervention as a Goal in Hypertension Treatment37

ModelINSIGHT (Italy)INSIGHT (Spain)INSIGHT (France)INSIGHT (Scandinavia)INSIGHT (Netherlands)INSIGHT (UK)
Age1.034 (0.961 - 1.113) (yrs)1.067 (0.981 - 1.160) (yrs)1.066 (0.997 - 1.141) (yrs)0.991 (0.893 - 1.100) (yrs)1.096 (1.016 - 1.181) (yrs)1.011 (0.975 - 1.049) (yrs)
Female0.720 (0.302 - 1.717)0.411 (0.159 - 1.059)0.478 (0.223 - 1.025)0.421 (0.135 - 1.311)0.376 (0.161 - 0.877)0.807 (0.539 - 1.208)
Total Cholesterol1.303 (1.045 - 1.625) (TotChol/HDL mg/dL)1.364 (1.002 - 1.858) (TotChol/HDL mg/dL)1.083 (0.866 - 1.354) (TotChol/HDL mg/dL)0.919 (0.630 - 1.340) (TotChol/HDL mg/dL)1.295 (1.063 - 1.578) (TotChol/HDL mg/dL)1.221 (1.099 - 1.356) (TotChol/HDL mg/dL)
Systolic BP1.000 (0.972 - 1.028) (mmHg)1.014 (0.987 - 1.042) (mmHg)0.988 (0.960 - 1.018) (mmHg)1.000 (0.970 - 1.031) (mmHg)0.999 (0.977 - 1.022) (mmHg)1.011 (0.999 -1.024) (mmHg)
Diabetes Mellitus1.270 (0.496 - 3.254) (Med use or FBG ≥140 mg/dL)1.174 (0.449 - 3.071) (Med use or FBG ≥140 mg/dL)2.850 (1.351 - 6.013) (Med use or FBG ≥140 mg/dL)1.187 (0.319 - 4.423) (Med use or FBG ≥140 mg/dL)0.925 (03.09 - 2.773) (Med use or FBG ≥140 mg/dL)1.640 (0.983 - 2.733) (Med use or FBG ≥140 mg/dL)
Smoker2.214 (0.912 - 4.946) (Current)1.256 (0.404 - 3.910) (Current)1.482 (0.670 - 3.275) (Current)1.783 (0.579 - 5.490) (Current)1.444 (0.643 - 3.242) (Current)1.248 (0.811 - 1.920) (Current)

From: Appendix H, Summary Table 5

Cover of Systematic Review of Cardiovascular Disease Risk Assessment Tools
Systematic Review of Cardiovascular Disease Risk Assessment Tools [Internet].
Evidence Syntheses/Technology Assessments, No. 85.
Matheny M, McPheeters ML, Glasser A, et al.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.